Odilorhabdin NOSO-95C
| Internal ID | 94f1a214-be52-4c9e-a280-ea4f850463c0 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides |
| IUPAC Name | (2S)-N-[(2S)-1-[[(2S)-6-amino-1-[[(Z)-1-[[(2S)-6-amino-1-(4-aminobutylamino)-1-oxohexan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopent-2-en-2-yl]amino]-1-oxohexan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-1-[(2R)-5-amino-2-[[2-[[(2S,3S)-4-amino-2-[[(2S,3S)-4-amino-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]pentanoyl]pyrrolidine-2-carboxamide |
| SMILES (Canonical) | C1CC(N(C1)C(=O)C(CCCN)NC(=O)CNC(=O)C(C(CN)O)NC(=O)C(C(CN)O)NC(=O)C(CCCCN)N)C(=O)NC(CC2=CN=CN2)C(=O)NC(CCCCN)C(=O)NC(=CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NCCCCN |
| SMILES (Isomeric) | C1C[C@H](N(C1)C(=O)[C@@H](CCCN)NC(=O)CNC(=O)[C@H]([C@H](CN)O)NC(=O)[C@H]([C@H](CN)O)NC(=O)[C@H](CCCCN)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CCCCN)C(=O)N/C(=C\CCN=C(N)N)/C(=O)N[C@@H](CCCCN)C(=O)NCCCCN |
| InChI | InChI=1S/C54H101N23O12/c55-18-4-1-12-33(62)45(81)75-44(41(79)28-61)52(88)76-43(40(78)27-60)51(87)68-30-42(80)70-37(15-9-22-59)53(89)77-25-11-17-39(77)50(86)74-38(26-32-29-65-31-69-32)49(85)73-35(14-3-6-20-57)47(83)72-36(16-10-24-67-54(63)64)48(84)71-34(13-2-5-19-56)46(82)66-23-8-7-21-58/h16,29,31,33-35,37-41,43-44,78-79H,1-15,17-28,30,55-62H2,(H,65,69)(H,66,82)(H,68,87)(H,70,80)(H,71,84)(H,72,83)(H,73,85)(H,74,86)(H,75,81)(H,76,88)(H4,63,64,67)/b36-16-/t33-,34-,35-,37+,38-,39-,40-,41-,43-,44-/m0/s1 |
| InChI Key | VFODIGMPMDOVDF-SLXJRBCYSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C54H101N23O12 |
| Molecular Weight | 1264.50 g/mol |
| Exact Mass | 1263.80000575 g/mol |
| Topological Polar Surface Area (TPSA) | 624.00 Ų |
| XlogP | -10.10 |
| Atomic LogP (AlogP) | -9.42 |
| H-Bond Acceptor | 22 |
| H-Bond Donor | 22 |
| Rotatable Bonds | 46 |
| CHEMBL4163760 |
| SCHEMBL19488055 |
| BDBM611535 |
| BDBM611540 |
| US10626144, Compound Odilomycin C |
| US10626144, Compound 22.12 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.7779 | 77.79% |
| Caco-2 | - | 0.8602 | 86.02% |
| Blood Brain Barrier | - | 0.5000 | 50.00% |
| Human oral bioavailability | - | 0.6143 | 61.43% |
| Subcellular localzation | Mitochondria | 0.7331 | 73.31% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8033 | 80.33% |
| OATP1B3 inhibitior | + | 0.9370 | 93.70% |
| MATE1 inhibitior | - | 0.7009 | 70.09% |
| OCT2 inhibitior | - | 0.6000 | 60.00% |
| BSEP inhibitior | + | 0.9616 | 96.16% |
| P-glycoprotein inhibitior | + | 0.7425 | 74.25% |
| P-glycoprotein substrate | + | 0.8474 | 84.74% |
| CYP3A4 substrate | + | 0.7347 | 73.47% |
| CYP2C9 substrate | - | 0.8055 | 80.55% |
| CYP2D6 substrate | - | 0.8108 | 81.08% |
| CYP3A4 inhibition | - | 0.8305 | 83.05% |
| CYP2C9 inhibition | - | 0.8728 | 87.28% |
| CYP2C19 inhibition | - | 0.8123 | 81.23% |
| CYP2D6 inhibition | - | 0.8916 | 89.16% |
| CYP1A2 inhibition | - | 0.7875 | 78.75% |
| CYP2C8 inhibition | + | 0.7816 | 78.16% |
| CYP inhibitory promiscuity | - | 0.9774 | 97.74% |
| UGT catelyzed | + | 0.8000 | 80.00% |
| Carcinogenicity (binary) | - | 0.9200 | 92.00% |
| Carcinogenicity (trinary) | Non-required | 0.5411 | 54.11% |
| Eye corrosion | - | 0.9847 | 98.47% |
| Eye irritation | - | 0.8962 | 89.62% |
| Skin irritation | - | 0.7337 | 73.37% |
| Skin corrosion | - | 0.9161 | 91.61% |
| Ames mutagenesis | - | 0.5254 | 52.54% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6713 | 67.13% |
| Micronuclear | + | 0.8800 | 88.00% |
| Hepatotoxicity | - | 0.6000 | 60.00% |
| skin sensitisation | - | 0.8375 | 83.75% |
| Respiratory toxicity | + | 0.8556 | 85.56% |
| Reproductive toxicity | + | 0.9333 | 93.33% |
| Mitochondrial toxicity | + | 0.7625 | 76.25% |
| Nephrotoxicity | - | 0.8803 | 88.03% |
| Acute Oral Toxicity (c) | III | 0.6029 | 60.29% |
| Estrogen receptor binding | + | 0.6508 | 65.08% |
| Androgen receptor binding | + | 0.6900 | 69.00% |
| Thyroid receptor binding | + | 0.6142 | 61.42% |
| Glucocorticoid receptor binding | + | 0.6411 | 64.11% |
| Aromatase binding | + | 0.7273 | 72.73% |
| PPAR gamma | + | 0.6560 | 65.60% |
| Honey bee toxicity | - | 0.7069 | 70.69% |
| Biodegradation | - | 0.8000 | 80.00% |
| Crustacea aquatic toxicity | + | 0.5200 | 52.00% |
| Fish aquatic toxicity | - | 0.7297 | 72.97% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 99.76% | 98.33% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 99.50% | 89.63% |
| CHEMBL2581 | P07339 | Cathepsin D | 99.44% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.44% | 96.09% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 99.01% | 100.00% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 98.76% | 96.67% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 98.64% | 97.23% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.40% | 91.11% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 98.40% | 88.42% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 97.66% | 97.09% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 97.33% | 98.94% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 96.87% | 95.52% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 96.65% | 94.45% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 96.20% | 90.20% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 96.10% | 93.10% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 95.78% | 96.28% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 95.69% | 98.24% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 95.63% | 97.21% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 95.56% | 96.67% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 95.54% | 97.64% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 95.05% | 82.69% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 94.44% | 98.10% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 94.28% | 82.86% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 93.88% | 100.00% |
| CHEMBL1907589 | P17787 | Neuronal acetylcholine receptor; alpha4/beta2 | 92.97% | 94.55% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 92.61% | 90.71% |
| CHEMBL233 | P35372 | Mu opioid receptor | 92.58% | 97.93% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 92.57% | 98.05% |
| CHEMBL2535 | P11166 | Glucose transporter | 91.14% | 98.75% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 91.11% | 99.17% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 90.97% | 96.90% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 90.67% | 91.81% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 90.49% | 93.33% |
| CHEMBL3837 | P07711 | Cathepsin L | 90.32% | 96.61% |
| CHEMBL3038469 | P24941 | CDK2/Cyclin A | 89.96% | 91.38% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 89.92% | 96.11% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 89.90% | 96.00% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 89.80% | 95.00% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 89.17% | 93.18% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 89.15% | 94.00% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 88.98% | 100.00% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 88.89% | 88.56% |
| CHEMBL236 | P41143 | Delta opioid receptor | 88.68% | 99.35% |
| CHEMBL3018 | Q9Y5Y6 | Matriptase | 88.60% | 98.33% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 88.39% | 90.08% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 88.16% | 95.89% |
| CHEMBL249 | P25103 | Neurokinin 1 receptor | 88.14% | 99.17% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 87.95% | 96.03% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 87.80% | 92.38% |
| CHEMBL204 | P00734 | Thrombin | 87.65% | 96.01% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 87.53% | 93.03% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 87.01% | 94.66% |
| CHEMBL1795117 | Q8TEK3 | Histone-lysine N-methyltransferase, H3 lysine-79 specific | 86.92% | 93.56% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 86.90% | 95.56% |
| CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 86.64% | 95.58% |
| CHEMBL2208 | P49137 | MAP kinase-activated protein kinase 2 | 86.18% | 95.20% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 85.93% | 95.89% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 85.49% | 93.00% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 85.46% | 80.71% |
| CHEMBL4208 | P20618 | Proteasome component C5 | 85.01% | 90.00% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 84.94% | 96.25% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 84.92% | 93.56% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 84.87% | 98.59% |
| CHEMBL3746 | P80365 | 11-beta-hydroxysteroid dehydrogenase 2 | 84.60% | 94.78% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 83.87% | 95.50% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 83.54% | 98.89% |
| CHEMBL325 | Q13547 | Histone deacetylase 1 | 83.26% | 95.92% |
| CHEMBL2803 | P43403 | Tyrosine-protein kinase ZAP-70 | 82.69% | 82.50% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 82.65% | 90.24% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 82.13% | 97.50% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 82.10% | 95.17% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 82.04% | 99.77% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 81.84% | 82.38% |
| CHEMBL4578 | Q14680 | Maternal embryonic leucine zipper kinase | 81.48% | 81.58% |
| CHEMBL5646 | Q6L5J4 | FML2_HUMAN | 81.30% | 100.00% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 81.27% | 91.19% |
| CHEMBL2973 | O75116 | Rho-associated protein kinase 2 | 80.55% | 96.73% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 132031638 |
| LOTUS | LTS0173178 |
| wikiData | Q105285474 |